Regeneron Pharmaceuticals Inc. (REGN) and French drug major Sanofi S.A. (SNYNF,SNY) announced Friday that Itepekimab met the primary endpoint in one of two trials of chronic obstructive pulmonary disease or COPD, while the second trial failed to meet the main goal. The companies said they are reviewing...
President Donald Trump has signed an Executive Order to bring the prices of prescription drugs in line with those paid by similar nations. The Order directs the U.S. Trade Representative and Secretary of Commerce to take action to ensure foreign countries are not engaged in practices that purposefully and unfairly undercut market prices and drive price hikes in the United States. The Order instr
The U.S. Food and Drug Administration has announced plans to expand the use of unannounced inspections at foreign manufacturing facilities that produce foods, essential medicines, and other medical products for American consumers and patients. This move builds upon the agency's Office of Inspection...
President Donald Trump has signed an Executive Order to facilitate the restoration of a robust domestic manufacturing base for prescription drugs, including key ingredients and materials necessary to manufacture prescription drugs. The Order directs the U.S. Food and Drug Administration to reduce the amount of time it takes to approve domestic pharmaceutical manufacturing plants by eliminating du
Drug major Johnson & Johnson (JNJ) announced Monday positive new data from the Phase 3 ASTRO study evaluating TREMFYA (guselkumab) subcutaneous (SC) induction therapy in adults with moderately to severely active ulcerative colitis or UC. The company noted that TREMFYA is positioned to become the first...
May 01, 2026 15:54 ET Central banks dominated the economics news flow this week with almost all major ones announcing their latest policy decisions and many boosted expectations for a rate hike in June. In other news, several countries released the preliminary data for first quarter economic growth. In the U.S., comments by Fed Chair Jerome Powell were also in focus as his term ends this month.